Menu
ncarol.com
  • Home
  • Real Estate
  • Business
  • Health
  • Non-profit
  • Beauty
  • Education
  • Services
  • Arts
ncarol.com

Large Independent Multi-Center Clinical Trial with Stratum Nutrition's NEM® Confirms Results in 7 Days
ncarol.com/10036789

Trending...
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 243
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • Little Wheels Adds Parent Recording to Vehicle Tales, Turning Bedtime Stories into Family Keepsakes
NEM brand eggshell membrane 26-171491
CARTHAGE, Mo. - ncarol.com -- Stratum Nutrition®, the Global Leader of eggshell and eggshell membrane wellness ingredients, and President, Micah Osborne, announce, "NEM® has become an internationally recognized joint health ingredient as supported in a large, double-blind, placebo-controlled Clinical Trial from Turkey."

The Journal of Arthritis (J Arthritis 8(4):285.) recently published a large independent multi-center, randomized double-blind, placebo-controlled trial evaluating the efficacy of Stratum's flagship ingredient, NEM® brand eggshell membrane, in 166 subjects diagnosed with Grade 2 or Grade 3 osteoarthritis of the knee.

This study was conducted at eight different university medical centers in Turkey and confirmed NEM®'s fast results in only 7 days. By Day 30, both knee pain and stiffness had improved by more than 30% in the NEM® -treated subjects. This study also employed a unique blinded, single-crossover design to compare subjects taking NEM® for 90 days versus subjects taking NEM® for 60 days (the former placebo subjects who began taking NEM® after Day 30). A responder analysis found a statistically significant difference between the number of patients having at least a 15% decrease in pain, which was greater in the 90-day NEM® group (71% of subjects) compared to the 60-day NEM® group (53% of subjects).

More on ncarol.com
  • Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
  • High Rise: Path to Nowhere (2022) — A High-Stakes Thriller Filmed in Charlotte, North Carolina
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • 15,000+ Fans Expected at the 2026 BIG HBCU Southern Classic Battle of the Bands in Charlotte
  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model

"This is the largest study conducted to date involving NEM® and we are pleased that it was supportive of its fast time to efficacy, even in subjects with moderate to severe arthritis. This, combined with its cartilage protecting effects recently demonstrated in healthy individuals, makes NEM® the perfect adjunctive therapy for those with joint issues," stated Kevin J. Ruff Ph.D., MBA – Sr. Director of Scientific & Regulatory Affairs for Stratum Nutrition.

For more information about Stratum Nutrition and its branded ingredients, please www.stratumnutrition.com.


About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, as well as oral-cavity probiotics, BLIS K12™ and BLIS M18™. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on ncarol.com
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
  • Railinc Launches RIGIS Routing+Mileage Application to Provide Accurate & Comprehensive Rail Routing
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity

NEM® & ESC® are trademarks of ESM Technologies, LLC, and are registered in the United States and other countries.

Ahiflower® is a registered trademark of Technology Crops International, LLC.

BLIS K12™ & BLIS M18™ are trademarks of Blis Technologies Limited and the subject of USA patent numbers 6773912 & 7226590.

Contact
Stratum Nutrition
***@stratumnutrition.com


Source: Stratum Nutrition
Filed Under: Business, Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • BET and Soul Train Awards - GONE! - Introducing The World Hip Hop Awards
  • Australian Aboriginal Cultural Immersions and First Nations Workshops
  • Soccer777 to Launch "Enjoy Soccer, Welcome the World Cup" Limited Edition Theme Soccer Set
  • Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
  • MROVI Trailer Parts Launches Its Own Tire Brand: Introducing MROVI Tires and the New Didgori Trail Tread
  • The NoNickel Gift Guide: Stylish, Skin-Safe Gifts Under $50 (and One Worth the Splurge)
  • AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders
  • Q4 2025 Outlook: JGCMGS Unveils High-Frequency Infrastructure for Italian and Global Markets
  • UK Financial Ltd Announces Full Ecosystem To Erc-3643 "SEC-Ready" Tokens For All UK Financial Ltd Tokenized Projects
  • Pushing the Wave Series Launches Premium Hardback Editions of 2017–2022 and 2023 Volumes
  • ZEELOOL 2025 Black Friday and Cyber Monday Big Deals
  • Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
  • A $7 Ticket Could Rewrite Someone's Destiny — 327 Acres of U.S. Land to Be Won by Anyone, Anywh
  • Bent Danholm Lists Contemporary Lakefront Residence in Winter Garden's Avalon Cove
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
  • NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
  • Little Wheels Adds Parent Recording to Vehicle Tales, Turning Bedtime Stories into Family Keepsakes
  • Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
_catLbl0 _catLbl1

Popular on ncarol.com

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 243
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • NFL Midseason 2025: Who's for Real and Who's Faking It?
  • PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • Wise Business Plans Launches Tailored Business Plan Writing Services for North Carolina Entrepreneur
  • Putting Your Roses to Bed for Winter in the Deep South - A Gentleman's Guide to Fall Rose Care
  • Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
  • Kaplan Morrell Law Firm Represents Former NHL Player in Workers' Compensation Case Drawing National Attention
  • Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis

Similar on ncarol.com

  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
  • Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute